Pharmacokinetic studies of DISIDA disposition. I. Animal studies.
The whole blood pharmacokinetics of intravenously administered 99mTc-disofenin (DISIDA) have been studied in dogs. Serial blood sampling permitted calculation of whole blood disposition rates, which principally represent liver clearance. There were striking differences in these rates between 6 normals and 7 animals in whom liver damage was induced by chronic bile duct ligation (256 vs 58 ml/min, P less than 0.001). Blood levels of radioactivity fell in a biexponential fashion characterized by rapid and slow disposition phases, whose half times were 2.4 and 58 min in normal animals. On 3 occasions, plasma was obtained from 1 animal by exsanguination 35 min after the administration of DISIDA and rapidly transfused into a 2nd animal. The whole blood pharmacokinetics of the second (recipient) animal showed a predominance of the slow disposition phase and a small rapid phase. The hepatic extraction ratio of blood radioactivity was measured in 3 dogs and was high (75%-90%) early after injection of DISIDA, but fell rapidly to remain around 10%. These experiments suggest the presence of two different species in the radiopharmaceutical studied, each being removed from the blood stream by the liver, but at different rates. The contribution of renal clearance to overall whole blood pharmacokinetics was negligible, since three nephrectomized dogs displayed similar pharmacokinetics to normals. Whole blood DISIDA pharmacokinetics are more complex than previously thought but appear to be capable of providing an accurate measure of liver function.
Fraser
I A
IA
Department of Surgery, Ohio State University, Columbus 43210.
Shaffer
P
P
Love
J
J
Staubus
A E
AE
Hinkle
G
G
Olsen
J
J
Carey
L C
LC
Fabri
P J
PJ
Ellison
E C
EC
D000818:Animals; D002779:Cholestasis / Q000097:blood / Q000000981:diagnostic imaging; D004285:Dogs; D007098:Imino Acids / Q000097:blood / Q000493:pharmacokinetics*; D007668:Kidney / Q000002:abnormalities / Q000000981:diagnostic imaging; D009942:Organometallic Compounds / Q000097:blood / Q000493:pharmacokinetics*; D011877:Radionuclide Imaging; D013667:Technetium; D019785:Technetium Tc 99m Disofenin
D007098:Imino Acids; D009942:Organometallic Compounds; D013667:Technetium; D019785:Technetium Tc 99m Disofenin